IMCC — IM Cannabis Corp.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Company profile
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: IL
- Exchange: NASDAQ
- Employees: 95
- Website: https://www.imcannabis.com
Latest SEC filings for IMCC
- EFFECT — 2026-10-21
- F-3 — 2026-10-08
- 6-K — 2026-10-02
- SCHEDULE 13G — 2026-09-30
- 6-K — 2026-09-28
- 6-K — 2026-09-25
- 6-K — 2026-09-24
- 6-K — 2026-09-23
- 6-K — 2026-09-23
- 6-K — 2026-09-02
Latest IMCC news
- — Whole Lotta Dank Debuts Dank Pack Across Alberta, Announces Nationwide Search for Cannabis Partners (GlobeNewswire Inc.)
- — Europe-focused operations change hands, while IM Cannabis retains its Israeli medical cannabis business. - Stock Titan (Stock Titan)
- — IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
- — A director has left IM Cannabis (IMCC) for personal reasons, with no disagreement cited. - Stock Titan (Stock Titan)
- — IM Cannabis Closes US$1.31 Million Direct Share Offering Amid Financial Strain - TipRanks (TipRanks)
- — Citing serious financial difficulty, IM Cannabis (IMCC) closes a share sale to raise cash. - Stock Titan (Stock Titan)
Educational tool only — not investment advice.